C

Consonance Capital

27 employees

Consonance Capital Partners is a healthcare investment firm that invests broadly across the healthcare landscape.

Investor insights

Sectors invested in

Health Care5
Biotechnology5
Medical4
Therapeutics4
Pharmaceutical2
Manufacturing2
Pathology1
clinical pathology1
Microbiology1
molecular testing1
Nail infection1
Molecular Laboratory1
Onychomycosis1
Dermatopathology1
skin cancer1
Therapeutic Solutions1
neuropathy1
icd-101
Lower Extremity1
Diagnostics testing1

Funding rounds participated in

$37M sweet spot round size

Most of their 8 investments are in rounds between $12M and $65M

Basic info

Industry

investment management

Sectors

Angel Investment
Health Care
Finance

Date founded

2005

Investments made

C

Civic Eagle raised $10M on May 11, 2022

Investors: Backstage Capital, Higher Ground Labs, M25, Debut Capital, Menlo Ventures and Consonance Capital

S

Surrozen raised $120M on August 12, 2021

Investors: The Column Group and Consonance Capital

S

Silence Therapeutics plc raised $46M on February 18, 2021

Investors: Great Point Partners, Adage Capital Management and Consonance Capital

M

Mersana Therapeutics raised $65M on April 7, 2020

Investors: Avoro Capital Advisors (formerly venBio Select Advisor) and Consonance Capital

B

Bako Diagnostics raised undisclosed on January 7, 2016

Investors: Consonance Capital

T

Telesta Therapeutics Inc. raised $29M on August 20, 2015

Investors: Omega Funds and Consonance Capital

e

excelleRx Inc raised undisclosed on March 1, 2014

Investors: Consonance Capital

C

Corindus Vascular Robotics raised $12M on April 14, 2008

Investors: HEALTHCOR LTD, BioStar Ventures, Technion R&D Ltd., Hudson Executive Capital and Consonance Capital

FAQ